Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Liver Cancer Therapeutics Market Growth in 2025?

The market size for liver cancer therapeutics has seen a rapid expansion in recent years. Expected to surge from $2.52 billion in 2024 to $2.95 billion in 2025, the market will experience a compound annual growth rate (CAGR) of 17.1%. Factors such as inflow of funds from governmental and non-profit entities, global escalation in healthcare spending, growth in health insurance penetration in developing nations, an aging global populace, and a rising incidence of obesity and diabetes can all be associated with the historical growth of this market.

What Is the Forecast for the Liver Cancer Therapeutics Market Size Through 2029?

The market for liver cancer therapeutics is predicted to experience a significant upswing in the coming years, projected to reach $5.50 billion by 2029 with a compound annual growth rate (CAGR) of 16.8%. This forecasted growth is attributed to multiple factors including the escalating global prevalence of liver cancer, rampant hepatitis B and C infections, ascending incidences of alcohol-related liver disease, and rising numbers of non-alcoholic fatty liver disease cases, coupled with the increasing reliance on immunotherapy approaches. The projected trends for the forecast period comprise the incorporation of Artificial Intelligence (AI) and Machine Learning (ML) in medicinal discovery, utilization of big data and real-world evidence in trial processes, the progression of sophisticated imaging technologies, the uptake of minimally intrusive diagnostic tools, as well as the integration of telemedicine and digital health in oncology follow-up care.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24283&type=smp

What are the Key Market Players in Liver Cancer Therapeutics Market and How They’re Evolving?

Major companies operating in the liver cancer therapeutics market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca PLC, Amgen Inc., Eli Lilly and Company , Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Eisai Co. Ltd., Ipsen, Exelixis Inc., BeiGene Ltd., Hutchmed, Celgene Corporation, Zymeworks Inc., Can-Fite BioPharma, Onyx Pharmaceuticals Inc.

What Are the Primary Growth Drivers in the Liver Cancer Therapeutics Market?

The escalating prevalence of hepatitis B infections is expected to influence the expansion of the liver cancer therapeutics market. Hepatitis B infection is a viral illness instigated by the hepatitis B virus (HBV), primarily impacting the liver and potentially leading to acute and chronic health issues, including liver cancer. The surge in hepatitis B infections is somewhat propelled by the growing use of injection drugs, which proliferate the virus via the exchange of tainted needles and syringes. Hepatitis B-related therapies are essential, as lasting infections could result in ongoing liver inflammation and cell damage, considerably augmenting the chances of malignant liver conditions over time. For instance, in 2024, the World Health Organization (WHO), a Switzerland-based international organization, documented over 254 million hepatitis B-positive individuals globally in 2022, and 1.2 million new cases were reported. Additionally, 83% of the 1.3 million deaths linked to viral hepatitis worldwide were due to hepatitis B. Hence, the escalating prevalence of hepatitis B infections is set to propel the growth of the liver cancer therapeutics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24283&type=smp

What Are the Leading Segments in the Global Liver Cancer Therapeutics Industry?

The liver cancer therapeutics market covered in this report is segmented –

1) By Type: Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, Other Types

2) By Therapy Type: Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, Other Therapy Types

3) By Distribution Channel Type: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

4) By End-Users: Pediatrics, Adults

Subsegments:

1) By Hepatocellular Carcinoma: Localized Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma

2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma

3) By Hepatoblastoma: Standard-Risk Hepatoblastoma, High-Risk Hepatoblastoma, Metastatic Hepatoblastoma

4) By Other Types: Fibrolamellar Carcinoma, Angiosarcoma Of The Liver, Hemangiosarcoma

What Are the Key Market Trends in the Liver Cancer Therapeutics Industry?

The liver cancer therapeutics market is witnessing a surge in innovations by major industry players who are focusing on creating groundbreaking treatments such as prescription immunotherapy drugs. These medications boost or inhibit the immune system to help combat specific illnesses, including cancer or chronic infections by specifically targeting and then modulating immune responses. For example, Bristol Myers Squibb, a top-tier biopharmaceutical company from the US, revealed in April 2025 that the U.S. Food and Drug Administration (FDA) had approved their Opdivo (nivolumab) and Yervoy (ipilimumab) treatments for adult patients suffering from hepatocellular carcinoma (HCC), the most common form of primary liver cancer that is either inoperable or has metastasized, to be used as a first-line treatment. The notable characteristic of this product is its approval which is based on the outcomes of the international Phase 3 Trial known as CheckMate-9DW. In this trial, patients with metastatic or untreatable HCC who hadn’t undergone systemic therapy before were allotted either the Opdivo combined with Yervoy or the investigator’s preferred tyrosine kinase inhibitor monotherapy (lenvatinib or sorafenib). This combined therapy showed a statistically meaningful improvement in overall survival (OS) and overall response rate (ORR) when paralleled with the comparator arm, thereby representing the only trial backing an FDA approval that exhibits superior results under these conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-cancer-therapeutics-global-market-report

What Is the Regional Outlook for the Liver Cancer Therapeutics Market?

North America was the largest region in the liver cancer therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/customise?id=24283&type=smp

This Report Delivers Insight On:

1. How big is the liver cancer therapeutics market, and how is it changing globally?

2. Who are the major companies in the liver cancer therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the liver cancer therapeutics market right now?

4. Which products or customer segments are growing the most in the liver cancer therapeutics market?

5. What factors are helping or slowing down the growth of the liver cancer therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model